by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

Revlon Group Holdings, LLC Warning Letter Details

Warning Letter

Revlon Group Holdings, LLC

Recipient Title Vice President of Operations, Revlon Group Holdings, LLC, 1501 Williamsboro St. Oxford , NC 27565 United States

Issue DateJune 02, 2026

FEI Number1021184

Violations4

CountryUnited States

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

CGMP/OTC Finished Pharmaceuticals/Adulterated

Revlon Group Holdings, LLC FDA Warning Letter, June 2, 2026